Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,469,612 shares of the medical equipment provider's stock after selling 125,824 shares during the period. Intuitive Surgical comprises 0.9% of Price T Rowe Associates Inc. MD's investment portfolio, making the stock its 16th largest position. Price T Rowe Associates Inc. MD owned 4.06% of Intuitive Surgical worth $7,552,560,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Norges Bank bought a new stake in Intuitive Surgical in the fourth quarter worth $2,401,493,000. Proficio Capital Partners LLC increased its holdings in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after buying an additional 948,902 shares during the period. Capital Research Global Investors lifted its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB boosted its position in Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

ISRG traded down $5.93 on Monday, reaching $508.66. 431,864 shares of the stock were exchanged, compared to its average volume of 1,612,472. Intuitive Surgical, Inc. has a fifty-two week low of $367.39 and a fifty-two week high of $616.00. The firm has a market capitalization of $181.17 billion, a PE ratio of 79.41, a PEG ratio of 5.85 and a beta of 1.55. The company's 50-day moving average price is $511.92 and its 200 day moving average price is $533.05.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the prior year, the company earned $1.50 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on ISRG shares. Piper Sandler dropped their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Barclays reduced their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday. Finally, UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $598.95.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 35,454 shares of company stock valued at $18,564,027. Company insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.